Ectin Research Competitors and Similar CompaniesClear all
Ectin Research's competitors and similar companies include iBio, Ikena Oncology, Barinthus Biotherapeutics and SystImmune.
 Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment. |  Barinthus Biotherapeutics Barinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. | ||||
Founding Date | Founding Date N/A | Founding Date 2008 | Founding Date 2016 | Founding Date 2016 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Mölndal, SE HQ | Locations San Diego, US HQ Bryan, US | Locations Boston, US HQ | Locations Oxford, GB HQ | Locations Redmond, US HQ |
Employees | Employees 7 | Employees 1630% decrease | Employees 5052% increase | Employees 33 | Employees 841% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 26.2 m | Valuation ($) 82.5 m | Valuation ($) 57.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $400k (FY, 2025) | Revenue (est.) $800k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income ($45.3m) (FY, 2025) | Net income ($66.5m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 53.7k (over 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 50m (almost 9 years ago) |
Total funding raised | Total funding raised $ 53.7k | Total funding raised $ 9.3m | Total funding raised $ 49m | Total funding raised $ 195.1m | Total funding raised $ 76m |
For sources of this data, please see the company profile
View Company Profiles
Ikena Oncology
HQ
Boston, US
Employees
50
Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.
View companyBarinthus Biotherapeutics
HQ
Oxford, GB
Employees
33
Barinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases.
View company
SystImmune
HQ
Redmond, US
Employees
84↑ 1% increase
Systimmune is a biopharmaceutical company focused on the treatment of cancer.
View company